Literature DB >> 20122500

Survivor treatment bias, treatment selection bias, and propensity scores in observational research.

Peter C Austin1, Robert W Platt.   

Abstract

Mesh：

Year:  2010        PMID： 20122500     DOI： 10.1016/j.jclinepi.2009.05.009

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  17 in total

Review 1.  Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence.

Authors:  Daniele Poole
Journal:  Blood Transfus       Date:  2015-11-20       Impact factor: 3.443

2.  Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index.

Authors:  Joshua D Mitchell; Brian F Gage; Nicole Fergestrom; Eric Novak; Todd C Villines
Journal:  J Vis Exp       Date:  2020-01-08       Impact factor: 1.355

3.  Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.

Authors:  Mohammad Ehsanul Karim; Paul Gustafson; John Petkau; Helen Tremlett
Journal:  Am J Epidemiol       Date:  2016-07-25       Impact factor: 4.897

4.  Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.

Authors:  Mohammad Ehsanul Karim; John Petkau; Paul Gustafson; Robert W Platt; Helen Tremlett
Journal:  Stat Methods Med Res       Date:  2016-09-21       Impact factor: 3.021

5.  Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Authors:  S Leone; V Ravasio; E Durante-Mangoni; M Crapis; G Carosi; P G Scotton; N Barzaghi; M Falcone; P Chinello; M B Pasticci; P Grossi; R Utili; P Viale; M Rizzi; F Suter
Journal:  Infection       Date:  2012-06-19       Impact factor: 3.553

6.  Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.

Authors:  Jordana B Cohen; Kevin C Eddinger; Jayme E Locke; Kimberly A Forde; Peter P Reese; Deirdre L Sawinski
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-25       Impact factor: 8.237

7.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

8.  Early resuscitation intensity as a surrogate for bleeding severity and early mortality in the PROMMTT study.

Authors:  Elaheh Rahbar; Erin E Fox; Deborah J del Junco; John A Harvin; John B Holcomb; Charles E Wade; Martin A Schreiber; Mohammad H Rahbar; Eileen M Bulger; Herb A Phelan; Karen J Brasel; Louis H Alarcon; John G Myers; Mitchell J Cohen; Peter Muskat; Bryan A Cotton
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

9.  Seven deadly sins in trauma outcomes research: an epidemiologic post mortem for major causes of bias.

Authors:  Deborah J del Junco; Erin E Fox; Elizabeth A Camp; Mohammad H Rahbar; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

10.  The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.

Authors:  John B Holcomb; Deborah J del Junco; Erin E Fox; Charles E Wade; Mitchell J Cohen; Martin A Schreiber; Louis H Alarcon; Yu Bai; Karen J Brasel; Eileen M Bulger; Bryan A Cotton; Nena Matijevic; Peter Muskat; John G Myers; Herb A Phelan; Christopher E White; Jiajie Zhang; Mohammad H Rahbar
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.